Fourpath Capital Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$873K Buy
2,411
+217
+10% +$74.3K 0.11% 128
2026
Q1
$772K Sell
2,194
-1,080
-33% -$385K 0.11% 122
2025
Q4
$1.07M Sell
3,274
-508
-13% -$161K 0.15% 98
2025
Q3
$1.07M Sell
3,782
-55
-1% -$16K 0.15% 96
2025
Q2
$1.07M Buy
3,837
+282
+8% +$79.9K 0.17% 87
2025
Q1
$1.11M Buy
3,555
+558
+19% +$165K 0.19% 87
2024
Q4
$781K Buy
2,997
+679
+29% +$201K 0.14% 104
2024
Q3
$747K Sell
2,318
-746
-24% -$244K 0.14% 108
2024
Q2
$957K Buy
3,064
+304
+11% +$89.3K 0.71% 27
2024
Q1
$785K Sell
2,760
-201
-7% -$58.8K 0.54% 40
2023
Q4
$853K Sell
2,961
-1,597
-35% -$435K 0.58% 34
2023
Q3
$1.23M Buy
4,558
+195
+4% +$48.7K 0.92% 22
2023
Q2
$969K Buy
4,363
+1,416
+48% +$329K 1.17% 23
2023
Q1
$712K Buy
2,947
+858
+41% +$211K 0.5% 51
2022
Q4
$549K Sell
2,089
-2,014
-49% -$540K 0.4% 65
2022
Q3
$925K Buy
4,103
+740
+22% +$179K 0.63% 38
2022
Q2
$818K Sell
3,363
-14
-0.4% -$3.43K 0.51% 46
2022
Q1
$817K Sell
3,377
-22
-0.6% -$5.05K 0.32% 58
2021
Q4
$765K Buy
+3,399
New +$717K 0.29% 66

Other funds holding AMGN

Fourpath Capital Management's AMGN Position: Q2 2026 in Review

Fourpath Capital Management increased its Amgen (AMGN) stake by 9.9% in Q2 2026, buying an estimated $74.3K and bringing the position to 2,411 shares worth $873K. The position accounts for 0.11% of the portfolio, ranked #128.

Fourpath Capital Management first reported a position in AMGN in Q4 2021 and has held it in 19 quarters since. The position peaked at $1.23M in Q3 2023. 1,447 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Fourpath Capital Management held 2,411 shares of Amgen worth $873K as of Q2 2026.
  • Fourpath Capital Management bought 217 Amgen shares in Q2 2026, an estimated $74.3K.
  • Amgen made up 0.11% of Fourpath Capital Management's portfolio in Q2 2026, its #128 holding.
  • Fourpath Capital Management first reported a position in Amgen in Q4 2021 and has held it in 19 quarters since.
  • Fourpath Capital Management's Amgen position peaked at $1.23M in Q3 2023.
  • 1,447 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Fourpath Capital Management's 13F filing for Q2 2026, filed 22 Jul 2026.